Skip to main content
Clinical Trials/NCT04688450
NCT04688450CompletedNot Applicable

Live User Acceptance Testing of a Decision Support System to Optimize Blood Pressure Management During Critical Care

Andrew Tomas Reisner1 site in 1 country20 target enrollmentStarted: January 21, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
20
Locations
1
Primary Endpoint
Data Completeness

Study Overview

Brief Summary

This is a feasibility study for an investigational clinical decision support system ("the System") intended to optimize the management of blood pressure (BP) for patients during vasopressor infusion. The investigational outcomes are the perceptions of the nurse-subjects who are managing the BP of the patient-subjects; the operational performance of the System; and any technical failures of the software during real-time operation.

Detailed Description

This is a feasibility study for an investigational clinical decision support system ("the System") intended to optimize the management of blood pressure (BP) for patients during vasopressor infusion. Enrollment is planned of a convenience sample of 20 individual patient-subjects and also the 20 nurse-subjects who correspond to the primary nurses managing the patient-subjects. Consent will be obtained by the investigative team from the patient-subject (or close family member or healthcare proxy) and from the nurse-subject. The nurse will receive training in the intended use and important limitations of the System. The System will be deployed to the patient's bedside and the System will be initiated. This intervention will continue for a duration of between 4 to 8 hours. A Technical Observer ("TO") will be present to continually oversee the operation of the System, watching to ensure that there are no observable technical failures. The TO will also watch to see if any early termination conditions are met (specifically any concerns by the clinical staff or the patient or the patient's family; any observed technical operational problems; maximum dose vasopressors or hypoxia despite maximum respiratory support; or unplanned bedside response by the clinical care team) and also will make annotations about the exact time that specific clinical interventions are performed. After the intervention, the nurse-subject will be surveyed. Prior to enrollment of a subsequent subject, additional data analysis -- sufficient to identify or exclude any early stoppage condition -- will be performed on the System's archived electronic data and log files. Any adverse events will be reported to the IRB and the FDA as per FDA and institutional policy.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Device Feasibility
Masking
None

Masking Description

No masking

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult patient (18 years or older) receiving continuous vasopressor infusion to maintain blood pressure;
  • •Clinician treating patient estimates future duration of vasopressor infusion likely at least 4 additional hours;
  • •Provider order has been made that sets lower limit for mean arterial pressure;
  • •Indwelling arterial catheter has been placed for continuous blood pressure monitoring.

Exclusion Criteria

  • •Lack of consent or at the discretion of the patient's primary nurse;
  • •The discretion of any of the patient's other clinical providers;
  • •People who do not speak English will be excluded. The rationale is that this protocol involves the bedside deployment of an investigational system plus longitudinal observation. Our mitigation for psychosocial risk involves a continual observer who can monitor for any evidence of subject psychosocial discomfort, which involves the ability to effectively communicate with the subject throughout the duration of the protocol. This therefore excludes patients who do not speak English.
  • •Patients who are on two simultaneous vasopressors running at maximum doses (per the ICUs own protocols) or who is on one maximum-dose vasopressor and has a contraindication to receiving a second vasopressor (e.g., insufficient vascular access).
  • •Patients who are hypoxic (SpO2 < 90%) despite maximum inspired oxygen (100% for patients receiving mechanical ventilation, or 10L high-flow in patients who are not candidates for mechanical ventilation).
  • •Provider order has been made that sets lower limit for SBP (because our system does not have the capability to provide decision-support for an SBP lower limit).
  • •Enhanced respiratory precautions for COVID.

Arms & Interventions

Intervention group

Experimental

The investigational system will be evaluated for safety and user acceptance in 20 patient-subjects and associated nurse-subjects

Intervention: VIGORIS Blood Pressure Management Clinical Decision Support System (Device)

Outcomes

Primary Outcomes

Data Completeness

Time Frame: Up to 8 hours

Completeness (yes/no) of flowsheet (data archive of the investigational System) without any lapses in input data from the bedside monitor during connectivity; and without lapses in associated BP forecasts.

Software Operation (Based on Review of Error Logs)

Time Frame: Up to 8 hours

Error-level and critical-level software errors in the runtime log (yes/no)

Quantitative Nurse-subject Survey Response

Time Frame: Up to 8 hours

Nurse-subject quantitative survey response (yes/no) about any confusion or perceived inaccuracies of the system; perceived risk of patient management error; or perceived distraction that impacted care delivery

Software Operation (Based on Real-time Observation)

Time Frame: Up to 8 hours

System malfunction (yes/no) observed in real-time by the Technical Observer

Secondary Outcomes

  • Percentage of Total SHEs Predicted by {Index > User's Index Threshold Setting} Prior to Earliest Hypotension (Outcome 3.2.3)(Up to 8 hours)
  • Percentage of Total SHE False Resolutions Detected by {Index > User's Index Threshold Setting} (Outcome 3.5.5)(Up to 8 hours)
  • Percentage of Total SHE False Resolutions Not Detected by {Index > User's Index Threshold Setting} With InOp State During False Resolution (Outcome 3.5.6)(Up to 8 hours)
  • Percentage of Total Stuttering Hypotension Episodes Detected by {Index > 35%} Prior to 10 Cumulative Min of Hypotension (Outcome 3.7.6)(Up to 8 hours)
  • Percentage of Total Stuttering Hypotension Episodes Not Detected by {Index > 35%} Prior to 10 Cumulative Min of Hypotension (Outcome 3.7.10)(Up to 8 hours)
  • Percentage of Total Stuttering Hypotension Episodes Not Detected by {Index > User's Index Threshold Setting} Prior to 10 Cumulative Min of Hypotension (Outcome 3.7.11)(Up to 8 hours)
  • Percentage of Time That the BP Forecast is Operative (Outcome 2.1)(up to 8 hours)
  • Accuracy of the MAP Forecast (Outcome 2.2)(Up to 8 hours)
  • Percentage of Time That the True Future 20 Min Median MAP Falls Within the Forecast Cone (Outcome 2.3)(Up to 8 hours)
  • SHE Incidence (Outcome 3.1)(Up to 8 hours)
  • Percentage of Total SHEs Predicted by {Index > 35%} Prior to Earliest Hypotension (Outcome 3.2.1)(Up to 8 hours)
  • Advance Warning Times (AWTs) for SHEs Predicted by {Index > 35%} Prior to Earliest Hypotension (Outcome 3.2.2)(Up to 8 hours)
  • AWTs for SHEs Predicted by {Index > User's Index Threshold Setting} Prior to Earliest Hypotension (Outcome 3.2.4)(Up to 8 hours)
  • Percentage of Total SHEs Predicted by {Index > 35%} Prior to Continuous Hypotension (Outcome 3.3.1)(Up to 8 hours)
  • AWTs for SHEs Predicted by {Index > 35%} Prior to Continuous Hypotension (Outcome 3.3.2)(Up to 8 hours)
  • Percentage of Total SHEs Predicted by {Index > User's Index Threshold Setting} Prior to Continuous Hypotension (Outcome 3.3.3)(Up to 8 hours)
  • AWTs for SHEs Predicted by {Index > User's Index Threshold Setting} Prior to Continuous Hypotension (Outcome 3.3.4)(Up to 8 hours)
  • Percentage of Total SHEs Detected by {Index > 35%} After Continuous Hypotension Onset (Outcome 3.4.1)(Up to 8 hours)
  • AWTs for SHEs Predicted by {Index > 35%} After Continuous Hypotension Onset (Outcome 3.4.2)(Up to 8 hours)
  • Percentage of Total SHEs Detected by {Index > User's Index Threshold Setting} After Continuous Hypotension Onset (Outcome 3.4.3)(Up to 8 hours)
  • AWTs for SHEs Predicted by {Index > User's Index Threshold Setting} After Continuous Hypotension Onset (Outcome 3.4.4)(Up to 8 hours)
  • Percentage of Total SHEs With False Resolutions (Outcome 3.5.1)(Up to 8 hours)
  • Percentage of Total SHE False Resolutions Detected by {Index > 35%} (Outcome 3.5.2)(Up to 8 hours)
  • Percentage of Total SHE False Resolutions Not Detected by {Index > 35%} With InOp State During False Resolution (Outcome 3.5.3)(Up to 8 hours)
  • Percentage of Total SHE False Resolutions Not Detected by {Index > 35%} Without InOp State During False Resolution (Outcome 3.5.4)(Up to 8 hours)
  • Percentage of Total SHE False Resolutions Not Detected by {Index > User's Index Threshold Setting} Without InOp State During False Resolution (Outcome 3.5.7)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} That Are Contiguous With SHEs (Outcome 3.6.1)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} That Are Contiguous With SHEs (Outcome 3.6.2)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} That Are Sentinel Notifications (Outcome 3.6.3)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} That Are Sentinel Notifications (Outcome 3.6.4)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} That Are False Notifications (Outcome 3.6.5)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} That Are False Notifications (Outcome 3.6.6)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} Contiguous With an SHE False Resolution (Outcome 3.6.7)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} Contiguous With an SHE False Resolution (Outcome 3.6.8)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} Contiguous With an SHE True Resolution, Overall (Outcome 3.6.9)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} Contiguous With an SHE True Resolution, Overall (Outcome 3.6.10)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} Contiguous With an SHE True Resolution, Suppressible (Outcome 3.6.11)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} Contiguous With an SHE True Resolution, Suppressible (Outcome 3.6.12)(Up to 8 hours)
  • Incidence of Notification Events {Index > 35%} With Onset During an SHE (Outcome 3.6.13)(Up to 8 hours)
  • Incidence of Notification Events {Index > User's Index Threshold Setting} With Onset During an SHE (Outcome 3.6.14)(Up to 8 hours)
  • Duration of False Notification Events {Index > 35%} (Outcome 3.6.15)(Up to 8 hours)
  • Duration of False Notification Events {Index > User's Index Threshold Setting} (Outcome 3.6.16)(Up to 8 hours)
  • Stuttering Hypotension Incidence (Outcome 3.7.1)(Up to 8 hours)
  • Percentage of Total Stuttering Hypotension Episodes Detected by {Index > 35%} Prior to the Stuttering Hypotension's First Hypotension (Outcome 3.7.2)(Up to 8 hours)
  • AWTs for Stuttering Hypotension Episodes Detected by {Index > 35%} Prior to the Stuttering Hypotension's First Hypotension (Outcome 3.7.3)(Up to 8 hours)
  • Percentage of Total Stuttering Hypotension Episodes Detected by {Index > User's Index Threshold Setting} Prior to the Stuttering Hypotension's First Hypotension (Outcome 3.7.4)(Up to 8 hours)
  • AWTs for Stuttering Hypotension Episodes Detected by {Index > User's Index Threshold Setting} Prior to the Stuttering Hypotension's First Hypotension (Outcome 3.7.5)(Up to 8 hours)
  • AWTs for Stuttering Hypotension Episodes Detected by {Index > 35%} Prior to 10 Cumulative Min of Hypotension (Outcome 3.7.7)(Up to 8 hours)
  • Percentage of Total Stuttering Hypotension Episodes Detected by {Index > User's Index Threshold Setting} Prior to 10 Cumulative Min of Hypotension (Outcome 3.7.8)(Up to 8 hours)
  • AWTs for Stuttering Hypotension Episodes Detected by {Index > User's Index Threshold Setting} Prior to 10 Cumulative Min of Hypotension (Outcome 3.7.9)(Up to 8 hours)

Investigators

Sponsor
Andrew Tomas Reisner
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Andrew Tomas Reisner

Attending Physician

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials